(19)
(11) EP 4 419 147 A1

(12)

(43) Date of publication:
28.08.2024 Bulletin 2024/35

(21) Application number: 22809036.1

(22) Date of filing: 21.10.2022
(51) International Patent Classification (IPC): 
A61K 47/10(2017.01)
A61K 9/08(2006.01)
A61K 47/02(2006.01)
A61K 47/40(2006.01)
A61K 9/00(2006.01)
A61K 31/00(2006.01)
A61K 47/20(2006.01)
A61P 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0019; A61K 9/08; A61K 47/02; A61K 47/10; A61K 47/40; A61P 1/00; A61K 47/20; A61K 31/4184; A61K 31/198; A61K 31/196; A61K 31/513
(86) International application number:
PCT/EP2022/079468
(87) International publication number:
WO 2023/067188 (27.04.2023 Gazette 2023/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.10.2021 LU 500779

(71) Applicant: Project Pharmaceutics GmbH
82152 Martinsried (DE)

(72) Inventors:
  • SCHÜTZ, Andreas
    82131 Stockdorf (DE)
  • WOLF, Helmut
    85665 Moosach (DE)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) LIQUID PHARMACEUTICAL FORMULATION